BI 1819479, Placebo, Film-coated tablet, matching in size, weight, colour and shape to BI 1819479 (both unit strengths), BI 1819479
1462-0004
Phase 2 small_molecule active
Quick answer
BI 1819479, Placebo, Film-coated tablet, matching in size, weight, colour and shape to BI 1819479 (both unit strengths), BI 1819479 for idiopathic pulmonary fibrosis is a Phase 2 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- idiopathic pulmonary fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active